Exploring Biomarkers for Huntington’s Disease
Huntington’s disease (HD) is a progressive, non-curative, autosomal dominant neurodegenerative disease characterized by prominent psychiatric problems, as well as progressive deterioration in both cognitive function and motor control. The success of therapeutic interventions in HD patients cannot be...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2022
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/81139 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Exploring Biomarkers for Huntington’s Disease
- Exploring the Effect of Genetic, Environmental and Lifestyle Factors on Multiple Sclerosis Susceptibility
- Biomarkers for Huntington’s Disease
- Neuroimaging Biomarkers for Huntington’s Disease
- Neuropathology of Huntington’s Disease
- Cognition in Huntington's Disease
- Endogenous Attention in Normal Elderly, Presymptomatic Huntington’s Disease and Huntington’s Disease Subjects